Vitturi, Giacomo
Crisafulli, Salvatore
Alessi, Ylenia
Frontalini, Sara
Stano, Marilisa Giustina
Fontana, Andrea
Giuffrida, Giuseppe
Ferraù, Francesco
Trifirò, Gianluca
Cannavò, Salvatore
Funding for this research was provided by:
Ministero dell’Istruzione, dell’Università e della Ricerca (2017N8CK4K)
Article History
Received: 31 January 2025
Accepted: 22 June 2025
First Online: 2 July 2025
Declarations
:
: Gianluca Trifirò has served, over the last 3 years, on advisory boards/seminars funded by Sanofi, MSD, Eli Lilly, Sobi, Celgene, Daichii Sankyo, Novo Nordisk, Gilead, and Amgen on topics not related to content of this paper; he is also a scientific coordinator of the academic spin-off “INSPIRE srl,” which has received funding from several pharmaceutical companies (Kiowa Kirin, Shonogi, Shire, Novo Nordisk, and Daichii Sankyo) for conducting observational studies and additional consultancy services on topics not related to the content of this paper. Additionally, he is currently a consultant for Viatris in a legal case concerning a topic not related to the content of this paper. The other authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.